BR112022011714A2 - Sistemas de distribuição oral com base em formação in situ de coacervados de proteína/polissacarídeo - Google Patents
Sistemas de distribuição oral com base em formação in situ de coacervados de proteína/polissacarídeoInfo
- Publication number
- BR112022011714A2 BR112022011714A2 BR112022011714A BR112022011714A BR112022011714A2 BR 112022011714 A2 BR112022011714 A2 BR 112022011714A2 BR 112022011714 A BR112022011714 A BR 112022011714A BR 112022011714 A BR112022011714 A BR 112022011714A BR 112022011714 A2 BR112022011714 A2 BR 112022011714A2
- Authority
- BR
- Brazil
- Prior art keywords
- protein
- polysaccharide
- powder
- situ formation
- coacervates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2063—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Abstract
SISTEMAS DE DISTRIBUIÇÃO ORAL COM BASE EM FORMAÇÃO IN SITU DE COACERVADOS DE PROTEÍNA/POLISSACARÍDEO. A presente invenção fornece um sistema de distribuição oral com base em formação in situ de coacervados de proteína/polissacarídeo. O sistema compreende um ingrediente ativo disperso em uma mistura em pó homogênea seca de uma proteína em pó e um polissacarídeo em pó, que pode formar uma coacervado complexo de proteína/polissacarídeos in situ mediante a imersão em fluido gástrico, desse modo conferindo proteção gástrica e/ou liberação modificada ao ingrediente ativo. Variar a razão de proteína em pó por polissacarídeo em pó no sistema de distribuição oral varia o nível de proteção gástrica e/ou a taxa de liberação no ingrediente ativo. A capacidade de o sistema aqui descrito ser com base em biopolímeros naturais e/ou naturalmente derivados provê vantagens comerciais em termos de aprovação regulatória e/ou crescente demanda de consumidores por tais produtos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962949130P | 2019-12-17 | 2019-12-17 | |
PCT/CA2020/051726 WO2021119810A1 (en) | 2019-12-17 | 2020-12-16 | Oral delivery systems based on in situ forming protein/polysaccharide coacervates |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112022011714A2 true BR112022011714A2 (pt) | 2022-09-06 |
Family
ID=76476907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112022011714A BR112022011714A2 (pt) | 2019-12-17 | 2020-12-16 | Sistemas de distribuição oral com base em formação in situ de coacervados de proteína/polissacarídeo |
Country Status (12)
Country | Link |
---|---|
US (2) | US11737987B2 (pt) |
EP (1) | EP3937983A4 (pt) |
JP (1) | JP2023506539A (pt) |
KR (1) | KR20220114618A (pt) |
CN (1) | CN114867496A (pt) |
AU (1) | AU2020406676A1 (pt) |
BR (1) | BR112022011714A2 (pt) |
CA (1) | CA3161198A1 (pt) |
IL (1) | IL293904A (pt) |
MX (1) | MX2022007326A (pt) |
WO (1) | WO2021119810A1 (pt) |
ZA (1) | ZA202206754B (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115886255A (zh) * | 2022-10-31 | 2023-04-04 | 中国农业大学 | 一种高稳定性蓝莓花色苷二元凝胶片剂及其制备方法 |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3069327A (en) | 1960-09-19 | 1962-12-18 | Arthur C Eldridge | Soybean whey protein-polysaccharide complex |
US3312594A (en) * | 1963-06-21 | 1967-04-04 | Squibb & Sons Inc | Longlasting troche |
US3558768A (en) | 1969-12-19 | 1971-01-26 | Sterling Drug Inc | Sustained release pharmaceutical compositions |
SE7607758L (sv) | 1975-07-28 | 1977-01-29 | Mueller Hans Dr Ing Fa | Sett for framstellning av eggvita ur vetemjol |
US4451446A (en) | 1982-03-04 | 1984-05-29 | Smithkline-Rit | Process for the preparation of polysaccharide-protein complexes from bacterial capsules, obtained products and immunogenic compositions containing them |
EP0109688A3 (en) | 1982-11-23 | 1986-12-03 | The Wellcome Foundation Limited | Improved complexes, processes for obtaining them and formulations containing such complexes |
GB2148901A (en) | 1983-10-04 | 1985-06-05 | Johnson & Johnson | Protein/polysaccharide complexes |
CA2257303C (en) | 1996-06-17 | 2006-04-04 | Janssen Pharmaceutica N.V. | Biconvex rapidly disintegrating dosage forms |
US6632451B2 (en) | 1999-06-04 | 2003-10-14 | Dexcel Pharma Technologies Ltd. | Delayed total release two pulse gastrointestinal drug delivery system |
PT2332581E (pt) | 2001-01-23 | 2015-10-16 | Sanofi Pasteur Inc | Vacina meningocócica tri- ou tetravalente de conjugados de polissacárido e crm-197 |
ES2398910T3 (es) | 2001-09-28 | 2013-03-22 | Tntgamble, Inc. | Sistema de aporte para componentes biológicos |
EP1371410A1 (en) | 2002-06-14 | 2003-12-17 | NIZO food research | Complex coacervates containing whey proteins |
ES2347045T3 (es) | 2002-11-04 | 2010-10-25 | Ocean Nutrition Canada Limited | Microcapsulas que tienen multiples cortezas, y metodo para su preparacion. |
CN1997282A (zh) | 2004-03-11 | 2007-07-11 | 马萨诸塞州立大学 | 脂质系统的生物聚合物包封和稳定性及其应用方法 |
KR100858848B1 (ko) | 2006-05-23 | 2008-09-17 | 한올제약주식회사 | 메트포르민 서방정 |
US20080254119A1 (en) * | 2007-04-16 | 2008-10-16 | Wyeth | Imbedded liquid lubricants for tableting |
KR100813224B1 (ko) * | 2007-08-24 | 2008-03-13 | 한양대학교 산학협력단 | 단백질 약물전달용 온도 가역성 코아세르베이트 조합 겔 |
IL188647A0 (en) | 2008-01-08 | 2008-11-03 | Orina Gribova | Adaptable structured drug and supplements administration system (for oral and/or transdermal applications) |
US8795724B2 (en) | 2008-06-12 | 2014-08-05 | Universite Laval | Modified protein excipient for delayed-release tablet |
EP2196097B1 (en) | 2008-12-04 | 2014-06-18 | Nestec S.A. | Hydrolysed protein-polysaccharide complexes |
US9167847B2 (en) * | 2009-03-16 | 2015-10-27 | Philip Morris Usa Inc. | Production of coated tobacco particles suitable for usage in a smokeless tobacoo product |
GB201005976D0 (en) | 2010-04-09 | 2010-05-26 | Univ Aston | A freeze-dried tablet |
KR20150142689A (ko) | 2013-03-15 | 2015-12-22 | 그린스트랙트, 엘엘씨 | 식물-기재 조성물 및 그의 용도 |
US20150050245A1 (en) | 2013-08-14 | 2015-02-19 | Tntgamble, Inc. | Methods and delivery system for beneficial additive and subtractive biological agents to promote balanced mammalian gastrointestinal flora |
US10166185B2 (en) * | 2015-06-09 | 2019-01-01 | J. Rettenmaier & Söhne Gmbh + Co Kg | Excipient and oral solid dosage forms for oily drugs |
JP6874681B2 (ja) | 2015-07-31 | 2021-05-19 | 不二製油株式会社 | 多糖類−タンパク質複合体の製造方法 |
US20190076535A1 (en) | 2017-02-20 | 2019-03-14 | Joshua Alan Held | Crosslinked protein-polysaccharide complexed consumable macrocapsule |
EP3634491B1 (en) * | 2017-06-06 | 2023-04-05 | BioGrund GmbH | Natural and organic binder compositions for oral solid dosage forms |
US11425924B2 (en) * | 2018-01-15 | 2022-08-30 | Glanbia Nutritionals, Ltd. | Composition and method for controlled-release of amino acids |
-
2020
- 2020-12-16 WO PCT/CA2020/051726 patent/WO2021119810A1/en unknown
- 2020-12-16 AU AU2020406676A patent/AU2020406676A1/en active Pending
- 2020-12-16 CA CA3161198A patent/CA3161198A1/en active Pending
- 2020-12-16 IL IL293904A patent/IL293904A/en unknown
- 2020-12-16 MX MX2022007326A patent/MX2022007326A/es unknown
- 2020-12-16 JP JP2022537400A patent/JP2023506539A/ja active Pending
- 2020-12-16 US US17/604,282 patent/US11737987B2/en active Active
- 2020-12-16 CN CN202080087533.1A patent/CN114867496A/zh active Pending
- 2020-12-16 EP EP20901042.0A patent/EP3937983A4/en active Pending
- 2020-12-16 KR KR1020227024387A patent/KR20220114618A/ko unknown
- 2020-12-16 BR BR112022011714A patent/BR112022011714A2/pt unknown
-
2022
- 2022-06-17 ZA ZA2022/06754A patent/ZA202206754B/en unknown
-
2023
- 2023-07-18 US US18/223,148 patent/US20230355531A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20230355531A1 (en) | 2023-11-09 |
KR20220114618A (ko) | 2022-08-17 |
ZA202206754B (en) | 2023-10-25 |
US11737987B2 (en) | 2023-08-29 |
WO2021119810A1 (en) | 2021-06-24 |
EP3937983A1 (en) | 2022-01-19 |
MX2022007326A (es) | 2022-09-23 |
US20220087941A1 (en) | 2022-03-24 |
AU2020406676A1 (en) | 2022-06-23 |
JP2023506539A (ja) | 2023-02-16 |
CN114867496A (zh) | 2022-08-05 |
IL293904A (en) | 2022-08-01 |
EP3937983A4 (en) | 2022-12-14 |
CA3161198A1 (en) | 2021-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112022011714A2 (pt) | Sistemas de distribuição oral com base em formação in situ de coacervados de proteína/polissacarídeo | |
Haase et al. | Zinc signals and immune function | |
SG195221A1 (en) | Valve devices, systems, and methods for controlling the distribution of materials | |
BRPI0519118A2 (pt) | composiÇço particulada prontamente dispersÁvel em Água, dispersço aquosa de distintas partÍculas intumescidas, produto alimentÍcio, fluido de perfuraÇço, composiÇço farmacÊutica, e, processos para preparar uma soluÇço de goma xantana e para manufaturar uma composiÇço particulada prontamente dispersÁvel em Água | |
BRPI0415549A (pt) | método e sistema para monitoração de fluxo de fluido | |
BR112015005278A2 (pt) | composições e métodos para encapsulação dupla de composto volátil | |
MX2010005159A (es) | Formulacion de recubrimiento enterico dispersable en agua para formas de dosificacion nutraceuticas y farmaceuticas. | |
ATE529100T1 (de) | Vektorsystem enthaltend nanopartikeln gleichmässiger grösse,welche aus zumindestens einem polymer und einem positiv geladenen polysaccharid bestehen,und herstellungsverfahren dieses systems | |
PL1954308T3 (pl) | Stabilizatory do liofilizowanych szczepionek | |
BR112017018987A2 (pt) | alimentador de partículas | |
BR112017014299A2 (pt) | sistema e método para proporcionar misturas de pó seco. | |
MX2009008487A (es) | Picoplatino encapsulado. | |
HK1146386A1 (en) | Pharmaceutical compositions containing at least one proteinaceous active ingredient protected against digestive enzymes | |
SA519410572B1 (ar) | تركيبات سماد مضاد للتكتل | |
National Advisory Committee on Microbiological Criteria for Foods | Response to questions posed by the Food and Drug Administration regarding virulence factors and attributes that define foodborne Shiga toxin-producing Escherichia coli (STEC) as severe human pathogens | |
SG10201803854VA (en) | Drain valve with rotatable angled outlet | |
CL2021000173A1 (es) | Composiciones para la agricultura y métodos relacionados. | |
MX2020005257A (es) | Composicion en polvo que comprende un agente ignifugo. | |
Chaplygin et al. | Steppe zone vegetation and soil layer pollution by heavy metals under the influence Novocherkassk Power Station emission | |
Taplitz et al. | Reply to MA Slavin et al | |
BR112022010974A2 (pt) | Composições orais com atividade de água reduzida | |
MX2020007321A (es) | Proceso para liberar un ingrediente activo. | |
Grace | Do Predators Affect the Survival of Macaria pallidata Larvae?: Implications for Biological Control of Mimosa pigra in the NT | |
Araki et al. | Protein kinase C-independent activation of Raf-1 and mitogen-activated protein kinase by leukotriene B4 in guinea pig eosinophils | |
MX2019004869A (es) | Una composicion para el cuidado personal que comprende particulas. |